Skip to content
Menu

Head-to-head comparison

Eden vs Shapely

Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.

Ranked #10Desk pick
Eden

High-disclosure compounded program — the clearest verification signals in the ranking — with a $99/mo medication price that only reads that low because the required $99/mo membership is billed separately.

$198/mo sema · $298/mo tirz · Verified August 2026

Marked down on: FDA issued Eden Health International Inc. dba Eden a warning letter in June 2026; the letter is public in FDA's warning-letter database

FDAWarning letter issued to Eden Health International Inc. dba Eden in June 2026. See the FDA warning-letter database.

vs
Ranked #299
Shapely

Shapely is a GLP-1 telehealth platform founded by Dr.

Marked down on: Currently available only in California, Florida, New York, and Texas — 46 states unserved despite announced expansion

Eden takes this head-to-head with the higher Desk Score, 87/100 (B+) against 63/100 (C) for Shapely. Shapely still holds its ground where its strengths line up with yours.

Desk Score, dimension by dimension

Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.

Eden

87/100

B+

Overall

Shapely

63/100

C

Price transparency

78
54

State access

96
42

Molecule range

88
79

Onboarding speed

82
47

Support responsiveness

90
92

Licensing & trust

92
83

The spec sheet

FieldEdenShapely
Semaglutide$198/mo$198/mo all-in month to month ($99/mo medication plus the required $99/mo Eden Membership; the membership is $39 for the first month, so $138 the first month; same price at every dose; no prepay tier is published; cancel anytime; compounded injectable)Not listed on Shapely's site (checked July 2026)
Tirzepatide$298/mo$298/mo all-in month to month ($199/mo medication plus the required $99/mo Eden Membership; the membership is $39 for the first month, so $238 the first month; same price at every dose; no prepay tier is published; cancel anytime; compounded injectable)Not listed on Shapely's site (checked July 2026)
CoverageAll 50 states4 states
Brand-nameYesYes
Oral optionInjectable onlyInjectable only
Best forPeople who weight clinical transparency and oversight over finding the cheapest rate, and who are fine with a two-line bill (medication plus membership) that comes to $198/mo semaglutide or $298/mo tirzepatide.Insurance-accepted telehealth with compounded sema $99/mo and tirz $166/mo; CA, FL, NY, TX (expanding).
Desk Score87/100B+63/100C

The verdict

Desk pick — Eden

Eden takes this head-to-head with the higher Desk Score, 87/100 (B+) against 63/100 (C) for Shapely. Shapely still holds its ground where its strengths line up with yours.

Choose Eden if…

People who weight clinical transparency and oversight over finding the cheapest rate, and who are fine with a two-line bill (medication plus membership) that comes to $198/mo semaglutide or $298/mo tirzepatide.

$198/mo sema · $298/mo tirz · All 50 states

FDAWarning letter issued to Eden Health International Inc. dba Eden in June 2026. See the FDA warning-letter database.

Choose Shapely if…

Insurance-accepted telehealth with compounded sema $99/mo and tirz $166/mo; CA, FL, NY, TX (expanding).

4 states

Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we write about a provider reads the same either way. Read full breakdowns: Eden · Shapely.

Also here

CoreAge Rx leads the whole ranking at 94/100

Whichever of these two you lean toward, our #1-rated provider outscores them both. One price at every dose, both molecules, all 50 states. The $99 and $149 figures are 12-month plans paid up front, not a monthly bill.

More head-to-heads

Or see the full comparison hub and the complete ranking.

Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.